JSPR · Jasper Therapeutics, Inc.
$0.70
+0.00 (+0.07%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$23.28M
Shares
33.27M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-20 | 425,251 | 3,363,237 | 3,788,488 | 56.8% |
| 2026-07-13 | 1,860,149 | 29,510,699 | 31,370,848 | 60.3% |
| 2026-07-06 | 184,442 | 2,055,200 | 2,239,642 | 69.4% |
| 2026-06-29 | 181,918 | 1,015,159 | 1,197,077 | 66.5% |
| 2026-06-22 | 236,928 | 2,666,471 | 2,903,399 | 67.9% |
| 2026-06-15 | 66,945 | 564,452 | 631,397 | 50.0% |
| 2026-06-08 | 107,836 | 905,919 | 1,013,755 | 58.5% |
| 2026-06-01 | 619,764 | 4,980,819 | 5,600,583 | 66.7% |
| 2026-05-25 | 57,698 | 337,212 | 394,910 | 43.1% |
| 2026-05-18 | 74,998 | 812,928 | 887,926 | 72.2% |
| 2026-05-11 | 105,380 | 747,954 | 853,334 | 55.9% |
| 2026-05-04 | 120,395 | 433,970 | 554,365 | 57.4% |
| 2026-04-27 | 115,217 | 478,141 | 593,358 | 59.3% |
| 2026-04-20 | 225,871 | 895,328 | 1,121,199 | 51.5% |
| 2026-04-13 | 267,244 | 973,122 | 1,240,366 | 46.4% |
| 2026-04-06 | 829,067 | 1,831,508 | 2,660,575 | 51.7% |
| 2026-03-30 | 510,722 | 1,098,797 | 1,609,519 | 52.5% |
| 2026-03-23 | 361,670 | 622,834 | 984,504 | 57.1% |
| 2026-03-16 | 131,653 | 363,418 | 495,071 | 45.2% |
| 2026-03-09 | 224,074 | 623,148 | 847,222 | 52.5% |
| 2026-03-02 | 219,521 | 1,331,174 | 1,550,695 | 60.4% |
| 2026-02-23 | 135,166 | 333,717 | 468,883 | 51.5% |
| 2026-02-16 | 532,558 | 361,895 | 894,453 | 53.8% |
| 2026-02-09 | 412,780 | 1,924,616 | 2,337,396 | 71.8% |
| 2026-02-02 | 399,216 | 989,061 | 1,388,277 | 56.7% |
| 2026-01-26 | 436,202 | 1,107,117 | 1,543,319 | 56.0% |
| 2026-01-19 | 380,711 | 846,401 | 1,227,112 | 61.5% |
| 2026-01-12 | 594,639 | 2,317,447 | 2,912,086 | 62.0% |
| 2026-01-05 | 762,412 | 5,676,884 | 6,439,296 | 64.7% |
| 2025-12-29 | 199,554 | 844,642 | 1,044,196 | 59.4% |
| 2025-12-22 | 116,928 | 2,101,739 | 2,218,667 | 78.2% |
| 2025-12-15 | 423,413 | 1,749,632 | 2,173,045 | 48.7% |
| 2025-12-08 | 376,169 | 1,202,978 | 1,579,147 | 44.8% |
| 2025-12-01 | 2,221,948 | 32,504,444 | 34,726,392 | 50.6% |
| 2025-11-24 | 347,064 | 602,437 | 949,501 | 59.4% |
| 2025-11-17 | 284,200 | 592,701 | 876,901 | 48.9% |
| 2025-11-10 | 477,783 | 948,511 | 1,426,294 | 57.4% |
| 2025-11-03 | 321,479 | 863,047 | 1,184,526 | 57.1% |
| 2025-10-27 | 218,055 | 701,382 | 919,437 | 50.5% |
| 2025-10-20 | 212,761 | 1,117,501 | 1,330,262 | 60.2% |
| 2025-10-13 | 278,031 | 509,008 | 787,039 | 48.7% |
| 2025-10-06 | 265,255 | 510,934 | 776,189 | 42.9% |
| 2025-09-29 | 177,702 | 1,847,637 | 2,025,339 | 76.3% |
| 2025-09-22 | 475,590 | 878,735 | 1,354,325 | 48.4% |
| 2025-09-15 | 145,858 | 1,207,570 | 1,353,428 | 58.3% |
| 2025-09-08 | 82,526 | 390,459 | 472,985 | 55.1% |
| 2025-09-01 | 64,414 | 228,479 | 292,893 | 52.2% |
Showing 1–47 of 47 weeks
Key facts
CIK
1788028
CUSIP
471871202
13F (30d)
52 filings
51 filers
Visit website
Investor relations